Bristol Myers Squibb (BMY) Consolidated Net Income (2009 - 2026)
Bristol Myers Squibb's Consolidated Net Income was $3.32 billion in Q2 2026, up 152.6% from $1.31 billion a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Consolidated Net Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bristol Myers Squibb's Consolidated Net Income was $9.27 billion through Jun 30, 2026, up 83.1% year-over-year; for FY2025, it was $7.06 billion.
- In earlier years, Consolidated Net Income was -$8.93 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
- The Q2 2026 figure marks the highest quarterly Consolidated Net Income since Q4 2009.
- Compared with a year earlier, Consolidated Net Income was higher in three of the last six quarters, with growth averaging 14.5%.
- The best year-over-year quarter for Consolidated Net Income over five years was Q2 2026 (growth of 152.6%); the worst was Q4 2024 (a decline of 95.7%).
- Per Business Quant data, BMY's Consolidated Net Income in the three quarters before Q2 2026 was $2.68 billion (Q1 2026), $1.09 billion (Q4 2025) and $2.2 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Bristol Myers Squibb | 125.78 Bn | 77.05 Bn | 9.25 Bn | 3.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 76.00 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.55 Bn |
API Access
Bristol Myers Squibb Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();